Cargando…

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.

Detalles Bibliográficos
Autores principales:	Lacout, Alexis, Marcy, Pierre Yves, Perronne, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518844/ https://www.ncbi.nlm.nih.gov/pubmed/32987193 http://dx.doi.org/10.1016/j.cmi.2020.09.027

Ejemplares similares

Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
por: Vedrines, Nicolas, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
por: Lacout, Alexis, et al.
Publicado: (2021)

Favorable Outcome after Treatment Using Antibiotics and Hydroxychloroquine in a Patient with Tumor Necrosis Factor Receptor-associated Periodic Syndrome: A 7-Year Follow-Up
por: Galperine, Tatiana, et al.
Publicado: (2020)

Chronotherapy in COVID-19 Disease
por: LACOUT, Alexis, et al.
Publicado: (2021)

The Persistent Lyme Disease: “True Chronic Lyme Disease” rather than “Post-treatment Lyme Disease Syndrome”
por: Lacout, Alexis, et al.
Publicado: (2018)

Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response
por: Fiolet, Thibault, et al.
Publicado: (2021)

RE: Role of Duplex Doppler US for Thyroid Nodules: Looking for the "Sword" Sign
por: Lacout, Alexis, et al.
Publicado: (2011)

RE: Tips and Tricks of Percutaneous Gastrostomy Under Image Guidance in Patients with Limited Access
por: Marcy, Pierre-Yves, et al.
Publicado: (2011)

Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response
por: Fiolet, Thibault, et al.
Publicado: (2021)

Seronegative spondyloarthropathy imaging: Looking at the past, hitting the future
por: Lacout, Alexis, et al.
Publicado: (2015)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
por: Hoang, Van Thuan
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load
por: Nguyen, Tuan V.
Publicado: (2021)

Problems with the analysis in “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19”
por: Atkinson, J. Graham
Publicado: (2020)

Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature
por: Goldman, Jason D., et al.
Publicado: (2021)

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend
por: Hor, Chee Peng, et al.
Publicado: (2020)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Jugular Vein Invasion Diagnosis and Prognosis in Thyroid Carcinomas
por: Marcy, Pierre Yves, et al.
Publicado: (2016)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Letter to the Editor re: Biglari et al. (2016)
por: Zura, Robert, et al.
Publicado: (2016)

Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
por: Varisco, Tyler J., et al.
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Re: Remdesivir for the treatment of COVID-19 by Lee et al.
por: Beccacece, Alessia, et al.
Publicado: (2023)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial
por: dos Santos, Marcelo Rodrigues
Publicado: (2021)

Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
por: Machiels, Julian D, et al.
Publicado: (2020)

Kaya et al. Is it a typical crosstalk: Need for re-implantation?
por: Akbarzadeh, Mohammad Ali
Publicado: (2015)

Re: ‘Post-COVID-19 chronic symptoms’ by Davido et al.
por: Miglis, Mitchell G., et al.
Publicado: (2021)

Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Saad, Mohamed O
Publicado: (2021)

Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Wambier, Carlos Gustavo
Publicado: (2021)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
por: Wiseman, David M.
Publicado: (2020)

Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome
por: Hraiech, Sami, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_78fbrqq5s4q1epom02b64dbpno